BioAtla (BCAB) EBIT (2020 - 2026)
BioAtla's (BCAB) quarterly EBIT came in at -$9.3 million in Q1 2026, up 47.16% year-on-year from -$6.3 million in Q1 2025, and down 0.57% quarter-over-quarter from -$9.3 million in Q4 2025.
BioAtla (BCAB) EBIT (2020 - 2026) Analysis & Trends
BioAtla's EBIT history runs 7 years deep, the most recent figure standing at -$9.3 million for Q1 2026.
- On a quarterly basis, EBIT rose 47.16% year-over-year to -$9.3 million in Q1 2026; TTM through Mar 2026 was -$51.0 million, a 24.0% increase from a year earlier, with the FY2025 full-year figure at -$59.3 million, up 19.8% from the prior year.
- EBIT retreated to -$9.3 million in Q1 2026 per BCAB's latest filing, from -$9.3 million in the prior quarter.
- Across five years, EBIT topped out at -$9.3 million in Q4 2025 and bottomed at -$37.2 million in Q2 2023.
- The 5-year median for EBIT is -$24.3 million (2022), against an average of -$22.4 million.
- Across the five-year window, EBIT sank 33.77% in 2023 and soared 67.82% in 2024, its largest moves.
- Year by year, EBIT stood at -$28.6 million in 2022, then rose by 0.08% to -$28.5 million in 2023, then soared by 43.08% to -$16.2 million in 2024, then surged by 43.03% to -$9.3 million in 2025, then decreased by 0.57% to -$9.3 million in 2026.
- Per Business Quant, the three latest BCAB EBIT figures stand at -$9.3 million (Q1 2026), -$9.3 million (Q4 2025), and -$13.8 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | BioAtla | 5.74 Mn | 5.74 Mn | - | -9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.31 Mn |
| Dec 31, 2025 | -9.26 Mn |
| Sep 30, 2025 | -13.79 Mn |
| Jun 30, 2025 | -18.65 Mn |
| Mar 31, 2025 | -17.61 Mn |
| Dec 31, 2024 | -16.24 Mn |
| Sep 30, 2024 | -11.27 Mn |
| Jun 30, 2024 | -21.97 Mn |
| Mar 31, 2024 | -24.46 Mn |
| Dec 31, 2023 | -28.54 Mn |
| Sep 30, 2023 | -35.02 Mn |
| Jun 30, 2023 | -37.20 Mn |
| Mar 31, 2023 | -28.93 Mn |
| Dec 31, 2022 | -28.56 Mn |
| Sep 30, 2022 | -26.18 Mn |
| Jun 30, 2022 | -29.06 Mn |
| Mar 31, 2022 | -24.35 Mn |
| Dec 31, 2021 | -23.49 Mn |
| Sep 30, 2021 | -23.70 Mn |
| Jun 30, 2021 | -30.46 Mn |